TORONTO and GATINEAU, Québec, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Converge Technology Solutions Corp. (“Converge” or “the Company”) (TSX:CTS) (FSE:0ZB) (OTCQX:CTSDF) is pleased to provide its financial results for the three and nine months ended September 30, 2021. All figures are in Canadian dollars unless otherwise stated.
Q321 Highlights
Subsequent to Quarter
“Converge continues to execute on all aspects of its strategy and we are extremely enthusiastic to have closed our platform acquisition in Europe. The Company continues to invest in talent and expand its service capabilities to its customers across North America and Europe, as reflected in our very impressive recurring revenue managed services growth,” stated Shaun Maine, CEO of Converge. “Additionally, the Company ended the quarter with $210 million of cash on-hand driven by extremely strong free cash generation from our business, with $190 million in available capacity under our ABL credit facility.”
Conference Call Details:
Date: Thursday, November 11th, 2021
Time: 8:00 AM Eastern Time
Participant Dial-in Numbers:
Toll Free – North America (+1) 888 708 0720
Toll Free – International (929) 517 9011
Germany – 0800 181 5287
United Kingdom – 0800 028 8438
Conference ID: 1936798
Recording Playback Numbers:
Toll Free – (855) 859 2056
Alternative Number – (800) 585 8367
Passcode: 1936798
Expiry Date: November 18th, 2021
A live audio webcast and archive of the conference call will be available by visiting the Company’s website at https://convergetp.com/investor-relations/. Please connect at least 15 minutes prior to the conference call to ensure time for any software download that may be needed to hear the webcast.
About Converge
Converge Technology Solutions Corp. is a software-enabled IT & Cloud Solutions provider focused on delivering industry-leading solutions and services. Converge’s regional sales and services organizations deliver advanced analytics, cloud, and cybersecurity offerings to clients across various industries. The Company supports these solutions with managed services, digital infrastructure, and talent expertise offerings across all major IT vendors in the marketplace. This multi-faceted approach enables Converge to address the unique business and technology requirements for all clients in the public and private sectors. For more information, visit convergetp.com.
For further information contact:
Converge Technology Solutions Corp.
Email: [email protected]
Phone: 416-360-1495
Summary of Condensed Interim Consolidated Statements of Financial Position
(expressed in thousands of dollars)
September 30, 2021 | December 31, 2020 | ||||
Assets | |||||
Current assets | |||||
Cash | $ | 210,344 | $ | 64,767 | |
Restricted cash | 11,467 | ||||
Trade and other receivables | 358,549 | 364,308 | |||
Inventories | 79,551 | 37,868 | |||
Prepaid expenses and other assets | 15,466 | 10,376 | |||
675,377 | 477,319 | ||||
Long-term assets | |||||
Property, equipment, and right-of-use assets, net | 28,805 | 23,558 | |||
Intangible assets, net | 238,618 | 108,926 | |||
Goodwill | 325,988 | 110,068 | |||
Other non-current assets | 1,272 | 749 | |||
$ | 1,270,060 | $ | 720,620 | ||
Liabilities and shareholders’ equity | |||||
Current liabilities | |||||
Trade and other payables | $ | 446,560 | $ | 398,003 | |
Borrowings | 849 | 133,281 | |||
Other financial liabilities | 35,808 | 22,125 | |||
Deferred revenue and other liabilities | 34,617 | 17,376 | |||
Income taxes payable | 5,769 | 764 | |||
523,603 | 571,549 | ||||
Long-term liabilities | |||||
Other financial liabilities | 88,303 | 28,858 | |||
Borrowings | 579 | 5,882 | |||
Deferred tax liability | 49,693 | 12,584 | |||
$ | 662,178 | $ | 618,873 | ||
Shareholders' equity | |||||
Common shares | 633,271 | 135,354 | |||
Contributed surplus | 1,193 | ||||
Exchange rights | 2,614 | 4,853 | |||
Foreign exchange translation reserve | 794 | 817 | |||
Deficit | (29,990) | (39,277) | |||
607,882 | 101,747 | ||||
$ | 1,270,060 | $ | 720,620 |
Summary of Condensed Interim Consolidated Statements of Income (Loss) and Comprehensive Income (Loss)
(expressed in thousands of dollars)
Three months ended September 30, | Nine months ended September 30, | ||||||||
2021 | 2020 | 2021 | 2020 | ||||||
Revenues | |||||||||
Product | $ | 289,591 | $ | 143,450 | $ | 823,385 | $ | 509,141 | |
Service | 77,758 | 46,425 | 199,473 | 150,101 | |||||
Total revenue | 367,349 | 189,875 | 1,022,858 | 659,242 | |||||
Cost of sales | 283,578 | 137,480 | 793,047 | 497,163 | |||||
Gross profit | 83,771 | 52,395 | 229,811 | 162,079 | |||||
Selling, general and administrative expenses | 66,092 | 38,942 | 173,365 | 128,518 | |||||
Income before the following | 17,679 | 13,453 | 56,446 | 33,561 | |||||
Depreciation and amortization | 10,162 | 5,180 | 24,548 | 16,204 | |||||
Finance expense, net | 1,528 | 5,138 | 5,675 | 15,953 | |||||
Special charges | 8,702 | 1,865 | 17,107 | 7,914 | |||||
Share-based compensation expense | 1,193 | - | 1,193 | - | |||||
Other expenses (income) | (8,491) | 506 | (5,485) | (114) | |||||
Income (loss) before income taxes | 4,585 | 764 | 13,408 | (6,396) | |||||
Income tax expense (recovery) | (11) | 70 | 4,121 | (1,271) | |||||
Net income (loss) | $ | 4,596 | $ | 694 | $ | 9,287 | $ | (5,125) | |
Other comprehensive income (loss) | |||||||||
Exchange (gain) loss on translation of foreign operations | 641 | (345) | 23 | 403 | |||||
Comprehensive income (loss) | $ | 3,955 | $ | 1,039 | $ | 9,264 | $ | (5,528) | |
Adjusted EBITDA | $ | 18,862 | $ | 14,619 | $ | 59,349 | $ | 37,119 |
Summary of Condensed Interim Consolidated Statements of Cash Flows
For the three months ended September 30, | For the nine months ended September 30, | |||||||||
2021 | 2020 | 2021 | 2020 | |||||||
Cash flows from operating activities | ||||||||||
Net income (loss) | $ | 4,596 | $ | 694 | $ | 9,287 | $ | (5,125) | ||
Adjustments to reconcile net income (loss) to net cash from operating activities | ||||||||||
Depreciation and amortization | 10,324 | 6,479 | 26,635 | 20,277 | ||||||
Unrealized foreign exchange losses (gains) | (7,991) | 401 | (5,025) | (608) | ||||||
Share-based compensation expense | 1,193 | - | 1,193 | - | ||||||
Finance expense, net | 1,528 | 5,138 | 5,675 | 15,953 | ||||||
Change in fair value of contingent consideration | 3,808 | - | 4,405 | - | ||||||
Income tax expense (recovery) | (11 ) | 70 | 4,121 | (1,271) | ||||||
13,447 | 12,782 | 46,291 | 29,226 | |||||||
Changes in non-cash working capital items | ||||||||||
Trade and other receivables | 34,045 | 15,887 | 93,065 | 45,947 | ||||||
Inventories | (7,103) | 2,501 | (31,290) | (1,159) | ||||||
Prepaid expenses and other assets | (4,146) | (313) | (4,447) | 4,927 | ||||||
Trade and other payables | 16,896 | (5,906) | (48,706) | (5,273) | ||||||
Income taxes payable | (634) | (195) | (2,613) | (845) | ||||||
Other financial liabilities | 6 | 3 | 1,877 | (405) | ||||||
Deferred revenue and customer deposits | (4,390) | 1,114 | 13,123 | 4,767 | ||||||
Cash from operating activities | 48,121 | 25,873 | 67,300 | 77,185 | ||||||
Cash flows from investing activities | ||||||||||
Purchase of property and equipment | (810) | (458) | (3,661) | (1,331) | ||||||
Proceeds on disposal of property and equipment | 421 | (2) | 552 | 252 | ||||||
Repayment of contingent consideration | - | - | (5,502) | (3,830) | ||||||
Repayment of deferred consideration | (1,879) | (4,306) | (5,627) | (9,077) | ||||||
Business combinations, net of cash acquired | (148,143 ) | - | (244,293) | (6,699) | ||||||
Cash used in investing activities | (150,411 ) | (4,766) | (258,531) | (20,685) | ||||||
Cash flows from financing activities | ||||||||||
Transfers to restricted cash | (11,467) | - | (11,467) | (250) | ||||||
Interest paid | (561) | (3,790) | (5,639) | (12,420) | ||||||
Payments of lease liabilities | (2,584) | (2,246) | (7,001) | (7,501) | ||||||
Proceeds from issuance of common shares | 248,370 | 50,730 | 493,886 | 60,387 | ||||||
Repurchase of common shares | - | - | - | (2,125) | ||||||
Repayment of notes payable | (376) | (83) | (3,790) | (257) | ||||||
Repayment of borrowings | (51,900) | (42,694) | (135,448) | (56,016) | ||||||
Cash from (used in) financing activities | 181,482 | 1,917 | 330,541 | (18,182) | ||||||
Net change in cash during the period | 79,192 | 23,024 | 139,310 | 38,318 | ||||||
Effect of foreign exchange on cash | 6,229 | (345) | 6,267 | 143 | ||||||
Cash, beginning of period | 124,923 | 36,372 | 64,767 | 20,590 | ||||||
Cash, end of period | $ | 210,344 | $ | 59,051 | $ | 210,344 | $ | 59,051 |
Adjusted EBITDA (Non-IFRS Financial Measurement)
Adjusted EBITDA represents net loss or income adjusted to exclude amortization, depreciation, interest expense and finance costs, foreign exchange gains and losses, income tax expense, and special charges. Special charges consist primarily of restructuring related expenses for employee terminations, lease terminations, and restructuring of acquired companies, as well as certain legal fees or provisions related to acquired companies. From time to time, it may also include adjustments in the fair value of contingent consideration, and other such non-recurring costs related to restructuring, financing, and acquisitions. The Company uses Adjusted EBITDA to provide investors with a supplemental measure of its operating performance and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. The Company believes that securities analysts, investors and other interested parties frequently use non-IFRS measures in the evaluation of issuers. Management also uses non-IFRS measures in order to facilitate operating performance comparisons from period to period, prepare annual operating budgets and assess the ability to meet capital expenditure and working capital requirements.
Adjusted EBITDA is not a recognized, defined or standardized measure under IFRS. The Company’s definition of Adjusted EBITDA will likely differ from that used by other companies and therefore comparability may be limited. Adjusted EBITDA should not be considered a substitute for or in isolation from measures prepared in accordance with IFRS. Investors are encouraged to review the Company’s financial statements and disclosures in their entirety and are cautioned not to put undue reliance on non-IFRS measures and view them in conjunction with the most comparable IFRS financial measures. The Company has reconciled Adjusted EBITDA to the most comparable IFRS financial measure as follows:
For the three months ended September 30, | For the nine months ended September 30, | ||||||||
2021 | 2020 | 2021 | 2020 | ||||||
Net income (loss) before taxes | $ | 4,585 | $ | 764 | $ | 13,408 | $ | (6,396) | |
Finance expense | 1,528 | 5,318 | 5,675 | 15,953 | |||||
Share-based compensation expense | 1,193 | 1,193 | |||||||
Depreciation and amortization | 10,162 | 5,180 | 24,548 | 16,204 | |||||
Depreciation included in cost of sales | 683 | 1,271 | 2,443 | 4,052 | |||||
Foreign exchange loss (gain) | (7,991) | 401 | (5,025) | (608) | |||||
Special charges | 8,702 | 1,865 | 17,107 | 7,914 | |||||
Adjusted EBITDA | $ | 18,862 | $ | 14,619 | $ | 59,349 | $ | 37,119 |
Forward-Looking Information
This press release contains certain “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities legislation regarding Converge and its business. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected” “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”. “estimates”, “believes” or intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Except as required by law, Converge assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change. The reader is cautioned not to place undue reliance on forward-looking statements.
For a detailed description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s filings statement available on SEDAR under the Company’s profile at www.sedar.com including its most recent Annual Information Form, its Management Discussion and Analysis and its Annual and Quarterly Financial Statements.